Persistence Market Research is released new forthcoming report on title "Type 1 Diabetes Market: Global Industry Analysis and Forecast to 2020".
New York, NY -- (SBWIRE) -- 12/10/2014 -- Diabetes refers to a group of metabolic disease characterized by high blood sugar level. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Some of the common symptoms for diabetes are frequent urination, excessive thirst, increased hunger, weight loss and tiredness. Type 1, type 2 and gestational diabetes are three types of diabetes. Type 1 diabetes is an autoimmune disease occurred due to high blood glucose level whereas, type 2 diabetes is a lifelong chronic diseases caused due to excess secretion of insulin inside the body. In type 1 diabetes, the immune system is activated against self-insulin producing cells. This results into low production of insulin and also disrupts blood glucose homeostasis. In type 1 diabetes, exposure to viral infection such as mumps and coxsackie viruses results into pancreas damage which results into low insulin secretion. Type 1 diabetes is highly prevalent in young people and children whereas type 2 diabetes is common type of diabetes. Some of the common symptoms for type 2 diabetes are overweight, high blood pressure and high triglycerides. Diabetes is treated with the help of insulin delivery devices and drugs. Diabetes diagnostic devices includes analog blood meter, test strips, lancets and lancing devices whereas, insulin delivery devices includes insulin syringe, insulin pump, insulin pen and insulin jet injectors. Severe problems such as blindness, kidney failure, coronary heart disease and strokes may result due to lack of proper treatment.
Buy Full Report:
North America is dominating the global type 1 diabetes market due to rising prevalence of diabetes. The U.S. is dominating the North American diabetes market. Asia Pacific region is expected to show high growth rate due to rising aging population in coming five years.
In recent time there is increased use of insulin delivery devices due to rising number of chronic diseases associated with diabetes. Rising awareness among people and technological advancement in insulin delivery devices are some of the key factors driving the growth of the global type 1 diabetes market. In addition, increasing government initiatives for diabetes control is also fuelling the growth of the global type 1 diabetes market. However, high cost of diagnosis and treatment is restraining the growth of the global type 1 diabetes market. In addition, unfavorable reimbursement policies are also inhibiting the growth of the global type 1 diabetes market.
Side effects associated with diabetes therapies could lead a challenge for the global type 1 diabetes market. Strong pipeline and development of molecules from newer class of diabetes drugs would be an opportunity for the growth of the global type 1 diabetes market. In addition, development of non-invasive diabetes diagnostics and drug delivery devices would also develop an opportunity for the growth of the global type 1 diabetes market. Increasing demand for artificial pancreas and home infusion therapy for diabetes treatment are some of the trend for the growth of the global type 1 diabetes market. Some of the major companies operating in the global type 1 diabetes market are Eli Lilly and Company, Astrazeneca Plc., B.Braun Melsungen AG, Novo Nordisk A/S, Sanofi-Aventis US, LLC, DiaVacs, Inc., XOMA Corp., Biodel, Inc. and Macrogenics, Inc.
Request Full Toc:
Key points covered in the report:
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.
About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-
disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.